Tag: Zydus
Zydus receives final approval from the USFDA
Zydus Lifesciences (formerly known as Cadila Healthcare), has received final approval from the United States Food and Drug Administration (USFDA) to market Empagliflozin and...
Zydus Covid vaccine shows possible 100% efficiency
Zydus Life Sciences, previously known as Cadila Healthcare's vaccine, ZyCov-D, a three-dose Covid Vaccine, has been authorized by the Subject Expert Committee (SEC) for...
Zydus receives final USFDA approval for Vigabatrin tablets
Ahmedabad, India, 20 January 2022, Zydus has received final approval from the USFDA to market Vigabatrin Tablets in the strength of 500 mg (US...
Zydus receives approval to conduct Covid-19 clinical trials in Mexico
Zydus Cadila announced that it had received approval from the Mexican regulatory authority COFEPRIS to conduct clinical trials with its biological therapy, Pegylated Interferon...
Zydus starts human dosing of its vaccine ‘ZyCoV-D’
Biotechnology Research Assistance Council (BIRAC) has announced that ZyCoV-D, the plasmid DNA vaccine designed and developed by Zydus and partially funded by the Department...
Zydus’ Covid-19 vaccine receives permission to initiate human clinical trials
Zydus, a global pharmaceutical company, announced that its plasmid DNA vaccine candidate for Covid-19 (ZyCoV-D) developed indigenously at its Vaccine Technology Centre in Ahmedabad,...
Zydus receives tentative approval from USFDA for Empagliflozin and Metformin Hydrochloride...
Zydus Cadila has received tentative approval from the USFDA to market Empagliflozin and
Metformin Hydrochloride Tablets, 5 mg/500 mg, 5 mg/1000 mg, 12.5 mg/500 mg,...
Zydus announces a drug to treat liver disease
Global pharmaceutical company, Zydus Cadila, announced that the Drug Controller General of India (DCGI) had approved its new drug application (NDA) for Saroglitazar, a...